Article

Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma

2022-12-07

Abstract excerpt

<h4>Background: </h4> and Objective: Lung adenocarcinoma is the most common and aggressive subtype of lung cancer, with the poor overall prognosis. IL2 is one of the earliest cytokines discovered that stimulates lymphocyte proliferation. However, the role of IL2 in LUAD has not been clarified. <h4>Methods: </h4>: UALCAN, The HPA and TIMER database were used to investigate IL2 expression in LUAD. HPA, PrognoScan Da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e93ba46d-fc41-55aa-a855-c75d0ad89e4d
DOI: 10.21203/rs.3.rs-2283797/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinomaDOI 10.21203/rs.3.rs-2283797/v1Read

Systematic construction and validation of an immune prognostic model for lung adenocarcinomaSemantic proximity Read

Establishment and validation of an immune-associated signature in lung adenocarcinoma.Semantic proximity Read

Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene setsSemantic proximity Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read

Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinomaSemantic proximity Read

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of lung adenocarcinomaSemantic proximity Read

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinomaSemantic proximity Read

An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity Read

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genesSemantic proximity Read

Construction of NEIL3 as a Prognostic Biomarker and Co-expressed Prognostic Signature in Lung AdenocarcinomaSemantic proximity Read

Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer AnalysisSemantic proximity Read

Identification and Validation of a Novel Prognostic Model of Inflammation-related Gene Signature of Lung AdenocarcinomaSemantic proximity Read